Cargando…
Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid
BACKGROUND: Huntington’s disease (HD) is a neurodegenerative syndrome that leads to marked decline in cognitive functioning along with uncharacteristic body movements called chorea. There exists no therapeutic agent to address the disease.3-Nitropropionic acid (3-NP) which is a suicide inhibitor of...
Autores principales: | Shetty, Shruthi, Hariharan, Ashwini, Shirole, Trupti, Jagtap, Aarti G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Indian Academy of Neurosciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410522/ https://www.ncbi.nlm.nih.gov/pubmed/26124545 http://dx.doi.org/10.5214/ans.0972.7531.220104 |
Ejemplares similares
-
Neuroprotective effects of Psoralea corylifolia Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid
por: Im, A-Rang, et al.
Publicado: (2014) -
Neuroprotective effect of silymarin against 3-Nitropropionic acid-induced neurotoxicity in rats
por: Chandolia, Priyanka, et al.
Publicado: (2022) -
Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction
por: Mehan, Sidharth, et al.
Publicado: (2018) -
Circadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid
por: Kudo, Takashi, et al.
Publicado: (2014) -
Neuroprotective effect of caffeic acid phenethyl ester in 3-nitropropionic acid-induced striatal neurotoxicity
por: Bak, Jia, et al.
Publicado: (2016)